Fig. 2From: NEAT1 can be a diagnostic biomarker in the breast cancer and gastric cancer patients by targeting XIST, hsa-miR-612, and MTRNR2L8: integrated RNA targetome interaction and experimental expression analysisRelative expression analysis of GEPIA2 online software, based on the TCGA RNA-seq datasets. According to the GEPIA2 data analysis, NEAT1 had a significantly low expression in the GC and BC samples compared to control samplesBack to article page